NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080221667

Registered date:06/12/2011

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedrheumatoid arthritis
Date of first enrollment06/12/2011
Target sample size
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : LY3009104 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : 1, 2, 4, 8 mg/day or placebo

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 75age old
GenderBoth
Include criteriaat least 6 swollen and at least 6 tender joints based on the 66/68 joint count; ACR functional class I, II, or III
Exclude criteria

Related Information

Contact

Public contact
Name
Address 0120-360-605
Telephone
E-mail
Affiliation Eli Lilly Japan K.K.
Scientific contact
Name
Address
Telephone
E-mail
Affiliation